Impact of asundexian on a panel of coagulation assays
Background: During the last few years, the small, oral, activated factor XI inhibitor, asundexian, has been investigated in different cardiovascular disorders. However, little is known about its impact on laboratory coagulation assays. Objectives: To describe the effects of asundexian on a panel of...
Spremljeno u:
| Glavni autori: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2025-07-01
|
| Serija: | Research and Practice in Thrombosis and Haemostasis |
| Teme: | |
| Online pristup: | http://www.sciencedirect.com/science/article/pii/S2475037925002742 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|